Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Low, PhD
University of California, Los Angeles
Principal Investigator - Michael Chuong, MD
Miami Cancer Institute
Principal Investigator - Parag J Parikh, MD
Henry Ford Health System
Principal Investigator - Percy Lee, MD
MD Anderson
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Assuta Medical Center
Tel Aviv, Israel
- Ucla
Los Angeles, California, United States
- Miami Cancer Institute
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Orlando Health
Orlando, Florida, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Henry Ford Health Sciences
Detroit, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Dartmouth-Hitchcock
Lebanon, New Hampshire, United States
- Cornell University
New York, New York, United States
- Providence Portland Cancer Center
Portland, Oregon, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University of Wisconisin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2019
- Primary completion
- 3 Aug 2022
- Completion
- 31 Jan 2027
- Last update posted
- 14 Oct 2022
- Registered enrollment
- 133
- Registry id
- NCT03621644
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.